Curtis L Triplitt

  • 1734 Citations
  • 23 h-Index
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1734 Citations
  • 23 h-Index
  • 39 Article
  • 14 Review article
  • 2 Editorial
  • 1 Chapter
Filter
Review article
2019

Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist

Patel, D., Triplitt, C. & Trujillo, J., Jan 1 2019, In : Advances in Therapy.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations
2014

Assessment of pancreatic β-cell function: Review of methods and clinical applications

Cersosimo, E., Solis-Herrera, C., Trautmann, M. E., Malloy, J. & Triplitt, C. L., Jan 1 2014, In : Current diabetes reviews. 10, 1, p. 2-42 41 p.

Research output: Contribution to journalReview article

96 Scopus citations

Novel agents for the treatment of type 2 diabetes

DeFronzo, R. A., Triplitt, C. L., Abdul-Ghani, M. & Cersosimo, E., May 2014, In : Diabetes Spectrum. 27, 2, p. 100-112 13 p.

Research output: Contribution to journalReview article

29 Scopus citations
2012

Examining the mechanisms of glucose regulation.

Triplitt, C. L., Jan 2012, In : The American journal of managed care. 18, 1 Suppl, p. S4-10

Research output: Contribution to journalReview article

28 Scopus citations

Understanding the kidneys' role in blood glucose regulation.

Triplitt, C. L., Jan 2012, In : The American journal of managed care. 18, 1 Suppl, p. S11-16

Research output: Contribution to journalReview article

36 Scopus citations
2010

Cardiac risk factors and hypoglycemia in an elderly patient: How good is good enough?

Triplitt, C., Jun 1 2010, In : Consultant Pharmacist. 25, SUPPL. B, p. 19-27 9 p.

Research output: Contribution to journalReview article

5 Scopus citations

Improving treatment success rates for type 2 diabetes: recommendations for a changing environment.

Triplitt, C., Aug 2010, In : The American journal of managed care. 16, 7 Suppl, p. S195-200

Research output: Contribution to journalReview article

15 Scopus citations
17 Scopus citations
2007

New technologies and therapies in the management of diabetes

Triplitt, C. L., Apr 1 2007, In : American Journal of Managed Care. 13, 2 SUPPL., p. S47-S54

Research output: Contribution to journalReview article

42 Scopus citations

The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes.

Triplitt, C., McGill, J. B., Porte, D. & Conner, C. S., Dec 2007, In : Journal of managed care pharmacy : JMCP. 13, 9 Suppl C, p. S2-16; quiz S17

Research output: Contribution to journalReview article

36 Scopus citations
2006

Drug interactions of medications commonly used in diabetes

Triplitt, C., Sep 1 2006, In : Diabetes Spectrum. 19, 4, p. 202-211 10 p.

Research output: Contribution to journalReview article

38 Scopus citations

Exenatide: From the gila monster to the pharmacy

Triplitt, C. & Chiquette, E., Jan 1 2006, In : Journal of the American Pharmacists Association. 46, 1, p. 44-55 12 p.

Research output: Contribution to journalReview article

31 Scopus citations

Incretin mimetics and dipeptidyl peptidase-IV inhibitors: Potential new therapies for type 2 diabetes mellitus

Triplitt, C., Wright, A. & Chiquette, E., Mar 1 2006, In : Pharmacotherapy. 26, 3, p. 360-374 15 p.

Research output: Contribution to journalReview article

42 Scopus citations

What are incretins, and how will they influence the management of type 2 diabetes?

Blonde, L., Rosenstock, J. & Triplitt, C., Sep 1 2006, In : Journal of Managed Care Pharmacy. 12, 7 SUPPL. A, p. S2-S12

Research output: Contribution to journalReview article

12 Scopus citations